Investors at the Cell & Gene Meeting on the Mesa expressed concern, though it may be a while before China can become a ...

Elixir Medical has won Japanese approval for its DynamX coronary bioadaptor. A launch is planned for mid-2027, while US ...

Malta-based B2B company Adalvo has announced plans to establish a new dedicated GLP-1 business unit focused on advancing ...

The South San Francisco company is developing therapies that target extracellular proteins, and its lead candidate is a food ...

Having failed a Phase II study for Parkinson’s monotherapy with its first-in-class GPR6 inhibitor, Cerevance will discuss the Phase III data showing benefit with solengepras as an adjunctive therapy ...

Ashwagandha tops consumer search interest across the US and five European markets, according to HBW Insight's Google Trends ...

European medical device market growth slowed to 1.8% in 2025 from 6.0%, and the number of medtech companies fell for the first time in the report’s history, according to MedTech Europe’s 2026 Facts & ...

Vertex Pharmaceuticals’ CDIO Agam Upadhyay outlines the firm’s three-pronged AI approach, the value realization framework keeping every deployment accountable and the CEO's seemingly impossible ask ...

A bipartisan Senate bill that would end the Trump Administration’s 340B rebate model pilot and create a national claims ...

Warnings mark a first for FDA about OTC topicals rendered unapproved due to labeling for STI treatment and latest action to ...

Kevin Lobo announced plans to step down as Stryker's CEO after 14 years in the role and 15 with the company, during which the ...

HHS' attorney said professional organizations cannot challenge the ACIP member appointments because no final agency action ...